Health and Safety

Lawmakers pledge support for NAFDAC

Lawmakers pledge support for NAFDAC
Written by Maritime First

The joint National Assembly (NASS) Committee on Health has pledged  continuous support for the National Agency for Food and Drug Administration and Control (NAFDAC) in its fight against counterfeit drugs.

Sen. Ibrahim Oloriegbe, the Senate Committee Chairman on Health and his counterpart Hon. Yusuf Sununu, Chairman House Committee on Healthcare Services made the commitment at the opening section of the 3rd African Medicine Quality Forum in Abuja on Tuesday.

The theme of the event is “Perfect vision for quality medicines in Africa 2020.”

Oloriegbe said the quality of medicine used by the people to cure or manage ailments is important in the healthcare delivery system of any nation.

The senator, representing Kwara central, said that with unhealthy citizens no nation would be able to fully harvest her potentials.

Also read: NAFDAC warns Nigerians against `Maishayi’ tea

He said the establishment of Africa Medicine Quality Forum (AMQF) as a continental organisation to pursue the eradication of substandard and falsified medicines is long awaited opportunity that we all must seize and make good use of.

He said the coming together of the medicine control laboratories of the national regulatory authority in Africa would ensure collaboration in fighting substandard and falsified medicines across Africa.

“The importance of quality control testing laboratories cannot be over emphasised in the medicine supply chain from the manufacturing plant, through the distribution network and finally to the patients,” Oloriegbe said.

He urged the agency to map out strategies for strengthening national quality control laboratories infrastructure and systems as it would help to inform and consistently regulate decisions in Africa.

He said that NASS would continue to provide necessary support for NAFDAC to attain the required world standard as a regulatory body.

Also, Sununu said that good legal framework underpins the ability of a national regulatory authority to fulfill its mandate and regulatory functions that span medical products life cycle.

This, according to Sununu, include: clinical trial, oversights, marketing authorisation and registration, licensing and inspection of premises, market surveillance among others.

He said that the lawmakers were committed to enacting laws and regulations that would ensure that only safe and efficacious medicine were available to citizens.

 

About the author

Maritime First